SWITZERLAND: ROCHE PILL AGAINST FLU

Article Abstract:

Tamiflu, an anti-influenza pill developed by Roche, has been approved by the Swiss pharmaceutical authority IKS. The product that was developed in cooperation with Gilead Sciences of California is said to be effective against all common influenza viruses. Switzerland is the first country to approve Tamiflu. Approval in the US is expected soon. Within 4-5 years the drug could generate a turnover of SFr 400mn to SFr 800mn.

Product introduction, Pharmaceutical Preparation Manufacturing, Antiinfective Preparations, Anti-infective agents, Gilead Sciences Inc., Roche Holding AG

---

Neues Institut gegr ndet

Article Abstract:

Institut f r praxisorientierte Qualifizierung (IPQ) has been set up in Basle to provide practically oriented education and further training for staff in the chemical and pharmaceutical industries. The founders of the institute are the Basle Polytechnic, Cilag AG of Schaffhausen, Pro-Transfer AG of Basle, Rohner AG of Pratteln and Siegfried CMS of Zofingen. The institute is financed with tuition fees.

Comment:

Switzerland: Institut f r praxisorientierte Qualifizierung is formed in Basle to offer education in chemical & drug inds

Facilities & equipment, Education of Adults, Educational Services, Adult education, Article

---

Similar abstracts:

• Abstracts: SWITZERLAND: CHRIST GIVES UP DIVISION. Switzerland: BWT wants all of Christ. UK: UV SYSTEMS BOUGHT BY GERMAN WEDECO
• Abstracts: SWITZERLAND: TIGHTER RULES ON PIG FARMING. US: BOEHRINGER VETMEDICA, EMBREX IN R&D DEAL. GERMANY: NEW R&D UNIT FOR INTERVET
• Abstracts: SWEDEN/GERMANY: CHEMETALL GROWS. UK: ACQUISITIONS BY KSB. SINGAPORE: HIESTAND TAKES OVER FINE SWISS FOODS
• Abstracts: SWITZERLAND: REORGANISATION OF SCHWEIZERHALL. GERMANY/AUSTRIA/ISRAEL: TEXTILE PRINTING R&D. Kooperation CSC mit Rolic Research
• Abstracts: GERMANY: NOVELTIES FROM FLORENA. GERMANY: ALTANA, GENE ALLIANCE GENOM RESEARCH. Accurec: ALD-Dach schafft Basis f r Angebotserweiterungen

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.